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Abstract
Purpose Attempts to estimate coronary flow reserve (CFR)
with single photon emission computed tomography
(SPECT) tracers have been recently made. We compared
two different methods for the estimation of CFR by SPECT
imaging.
Methods Fourteen patients with coronary artery disease
underwent dipyridamole 99mTc-sestamibi SPECT and intra-
coronary Doppler within 5 days. Myocardial blood flow
(MBF) was estimated by measurement of first transit counts
in the right pulmonary artery (PA) and left ventricular (LV)
chamber, and myocardial counts from SPECT images.
Estimated CFR was expressed as the ratio of stress MBF
to rest MBF.
Results Rest and stress MBF obtained using first transit
counts from PA were higher compared to that from LV
chamber (rest: 1.05±0.38 vs 0.87±0.34 counts/pixel per s,
respectively, p<0.01 and stress: 1.34±0.45 vs 0.91±0.20
counts/pixel per s, respectively, p<0.05). In the study
vessels, CFR by Doppler was 1.39±0.42, and SPECT
CFR obtained using first transit counts from PA and LV
chamber were 1.36±0.43 and 1.16±0.39, respectively
(p across categories NS). A significant relationship between
SPECT CFR obtained using first transit counts from PA and
CFR by Doppler was found (r=0.85, p<0.001). No
relationship between SPECT CFR obtained using first
transit counts from LV chamber and CFR by intracoronary
Doppler was observed (r=0.43, p = NS).
Conclusion SPECT-estimated CFR obtained using first
transit counts from right PA is more accurate and correlates
better with the results of intracoronary Doppler than
estimated CFR obtained using arterial input function from
LV chamber.
Keywords Coronary flow reserve . Sestamibi imaging .
Arterial input function
Introduction
The assessment of myocardial ischaemia is crucial to decide
which type of work-up is indicated in patients with
coronary artery disease (CAD). Single photon emission
computed tomography (SPECT) myocardial perfusion
imaging represents a validated diagnostic tool for the
evaluation of patients with suspected or known CAD [1–4].
Nevertheless, it retains some boundaries due to a limited
quantitative capability, especially in patients with diffuse
CAD [5, 6]. Measurement of coronary flow reserve (CFR)
may be helpful in assessing the functional status of
coronary vessels in order to determine disease severity
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and effectiveness of implemented therapies [7–10]. The
haemodynamic significance of lesions in epicardial vessels
has been characterized by invasive techniques such as
intracoronary Doppler which provide a direct assessment of
coronary flow velocity and relative flow reserve [11, 12].
Cardiac positron emission tomography (PET) allows non-
invasive and accurate quantitative measurements of myo-
cardial blood flow (MBF) and CFR [13–15]. PET-based
measurement of MBF is useful to assess coronary vasomotor
alterations and preclinical but evolving atherosclerosis.
However, PET technology has not been routinely employed
because of economic and logistic constrains. In this context,
SPECTwith 99mTc-labelled tracers has played a key role for
the evaluation of myocardial perfusion in patients with
CAD [1–4]. Recently, efforts to estimate CFR with SPECT
tracers have produced encouraging results [16–29]. In
particular, a good agreement of this technique with the
results obtained by invasive methods has been showed
[16, 18, 19]. However, when this procedure is applied
several issues might affect absolute quantitation: some
related to low-resolution factors and others dealing with the
accuracy of measuring arterial input function. In particular,
by using dynamic planar imaging the measurement of input
function may be affected by the spillover from adjacent
structures and it is not possible to separate the contribution
of the myocardium from the left ventricular (LV) chamber
blood as well as to avoid the interference of the right
ventricle and aorta. The aim of this study was to compare
two different computing methods for the estimation of CFR
by SPECT imaging with the results of intracoronary
Doppler technique in patients with CAD.
Materials and methods
Study population
This study included 14 consecutive patients (11 men, mean
age: 54±7 years) with documented CAD in whom
percutaneous coronary intervention was planned. No
patients had echocardiographic evidence of LV hypertrophy.
Two patients had diabetes mellitus and three patients
systemic arterial hypertension. At the time of the study, all
patients were in clinically stable condition, and patients were
taking β-blockers (n=3), angiotensin-converting enzyme
inhibitors (n=3) and nitrates (n=6). Patients with previous
myocardial infarction were excluded. Within 5 days, all
patients underwent an intracoronary Doppler study and
99mTc-sestamibi imaging. No clinical modification occurred
or therapy change was adopted between the SPECT and the
Doppler study. All patients were carefully instructed to
refrain from oral intake of methylxanthines, including
caffeine, during the 24 h before the SPECT and Doppler
studies under dipyridamole stress. Global CFR and that
computed in the culprit vessel of such patients has already
been compared with CFR measured in corresponding
territories of subjects with suspected CAD and normal
vessels at coronary angiography in our laboratory [16]. The
Ethics Committee of our university approved the protocol,
and each patient gave informed consent.
Sestamibi imaging
All patients underwent dipyridamole and rest cardiac
imaging. Dipyridamole was infused intravenously at a dose
of 0.74 mg/kg body weight given over a 6-min period with
monitoring of symptoms, blood pressure and 12-lead
electrocardiography [30]. No patients had severe angina or
hypotension or developed other intolerable side effects.
99mTc-sestamibi, 555 MBq, was injected intravenously as a
bolus 1–2 min before completion of the stress test.
Dynamic planar images were acquired for 60 s (4 frames/s)
in the anterior view to measure the first transit counts in the
pulmonary artery (PA) and in the LV chamber. SPECT
imaging was performed 60 min later. Data were acquired
with a rotating single-head gamma camera (Elscint SP4HR,
Elscint, Haifa, Israel) connected with a dedicated computer
system. Thirty-two projections (30 s/projection) were
obtained over a semicircular 180° arc, which extended from
the 30° right anterior oblique to the left posterior oblique
position. A 20% symmetric energy window centred on the
140-keV peak was used. Filtered backprojection was then
performed with a low-resolution Butterworth filter with a
cut-off frequency of 0.5 cycles per pixel and order of 5.0. No
attenuation or scatter correction was applied. Rest imaging
was performed on a separate day following the same
acquisition protocol.
For first-pass analysis, serial images of the first transit
study were evaluated frame by frame, and on the summed
image (3–5 s duration), 3 × 2-pixel regions of interest (ROI)
were assigned at the main right PA and at LV chamber.
After algorithm smoothing over a mean of 3 points, the area
under the time-activity curve was calculated to obtain the
time integral of the first-pass tracer counts for both PA and
LV (∫[C(t)dt]). Sestamibi activity was measured on two
representative short-axis tomograms (at mediobasal and
medioapical levels). For each short-axis tomogram, a global
ROI including the whole myocardial thickness was
assigned. In addition, each tomogram was divided into six
sectors of equal arc, representing the anterolateral, lateral,
inferior, posteroseptal, septal and anterior myocardium, and
a regional ROI was located in the corresponding sector.
Tracer activity was expressed as absolute myocardial
counts, and mean tracer uptake for each major coronary
territory was calculated. Counts from PA, LV and myocar-
dium were not corrected for background. To directly
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compare the results of sestamibi imaging with those of
intracoronary Doppler, each segment was assigned to one of
the major vascular territories. In brief, the left anterior
descending artery territory included the anterior and antero-
lateral walls and septum. The right coronary artery was
assigned the posteroseptal and inferior walls. The left
circumflex artery was assigned the lateral wall. Estimated
MBF under stress and resting conditions was measured as
myocardial counts/(∫[C(t)dt]) considering the input function
obtained from both right PA and LV. It was expressed as
counts/pixel per s. Estimated CFR was expressed as the ratio
of stress MBF to rest MBF. The accuracy and reproducibility
of this method have been previously reported [16].
Intracoronary Doppler study
Intracoronary CFR measurements with Doppler guide wires
were performed in stenotic vessels in which percutaneous
coronary intervention was planned immediately before treat-
ment. In brief, CFR was continuously evaluated starting at
baseline and during dipyridamole infusion. As for sestamibi
imaging, dipyridamole was infused intravenously at a dose of
0.74 mg/kg body weight given over a 6-min period with
monitoring of symptoms, blood pressure and 12-lead electro-
cardiography [30]. No patients developed severe angina,
hypotension or other intolerable side effects. FloMap 5500
(Cardiometrics Inc., Rancho Cordova, CA, USA) and
Doppler flow wire (0.014-inch, 12-MHz FloWire, Cardio-
metrics Inc., Rancho Cordova, CA, USA) were used. The tip
of the flow wire was carefully positioned as distally as
possible and, in any case, beyond the stenosis. Intravascular
velocity measurement was achieved at rest and during
maximal vasodilatation induced by dipyridamole infusion.
CFR was calculated by the ratio of mean maximal systolic-
diastolic velocity at hyperaemia to the corresponding
velocity at rest, by use of a machine-incorporated software
system. Examinations were recorded on S-VHS videotape.
Statistical analysis
Continuous data were expressed as mean ± SD. One-way
analysis of variance (ANOVA) was used for comparing
means between groups. Post hoc analysis with Bonferroni
correction was performed. Differences between mean
values were assessed by Student’s t test (two-tailed
probability) for paired data. Linear regression analysis was
used to assess the relationship between CFR estimated by
sestamibi using ROI on both PA and LV and by the
intracoronary Doppler technique. A p value < 0.05 was
considered statistically significant. Bland-Altman analysis
was also used to evaluate the agreement between the
techniques [31]. With this method, the differences between
two techniques are plotted against the means of the two
techniques. If the limits of agreement (mean ± 1.96 times
the SD of the differences) are not clinically important, the
two methods may be considered interchangeable.
Results
In each patient, Doppler flow velocity was measured in
stenotic vessels in which percutaneous coronary interven-
tion was planned. The individual study vessels and the
degree of coronary artery stenosis are shown in Table 1. In
the study vessel, SPECT-estimated rest and stress MBF
obtained using first transit counts from PA were higher as
compared to that from LV chamber (rest: 1.05±0.38 vs
0.87±0.34 counts/pixel per s, respectively, p<0.01 and stress:
1.34±0.45 vs 0.91±0.20 counts/pixel per s, respectively,
p<0.05) (Fig. 1).
Patient Study vessel Coronary artery stenosis (%)
1 Right coronary artery 75
2 Left circumflex coronary artery 75
3 Left anterior descending coronary artery 90
4 Left anterior descending coronary artery 85
5 Left anterior descending coronary artery 90
6 Right coronary artery 75
7 Right coronary artery 75
8 Left anterior descending coronary artery 75
9 Left anterior descending coronary artery 75
10 Left anterior descending coronary artery 75
11 Right coronary artery 65
12 Left circumflex coronary artery 60
13 Left anterior descending coronary artery 70
14 Left anterior descending coronary artery 65
Table 1 Individual study vessel
and degree of coronary artery
stenosis from patients undergoing
CFR assessment by sestamibi
imaging and intracoronary
Doppler
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CFR measured by intracoronary Doppler was 1.39±
0.43, and corresponding SPECT-estimated CFR obtained
using first transit counts from PA and LV chamber were
1.36±0.51 and 1.16±0.33, respectively (p across categories
NS). A significant relationship between SPECT-estimated
CFR obtained using first transit counts from PA and CFR
by intracoronary Doppler was found (r=0.85, p<0.001)
(Fig. 2). On the contrary, no relationship between SPECT-
estimated CFR obtained using first transit counts from LV
chamber and CFR by intracoronary Doppler was observed
(r=0.23, p = NS) (Fig. 3).
The mean difference between SPECT-estimated CFR
obtained using first transit counts from PA and by intra-
coronary Doppler was 0.02, the SD of differences 0.23, and
the lower and upper limits of agreement between the two
techniques were −0.44 and 0.48, respectively (Fig. 4). On
the other hand, the mean difference between SPECT-
estimated CFR obtained using first transit counts from LV
chamber and by intracoronary Doppler was 0.22, the SD of
differences 0.33, and the lower and upper limits of
agreement between the two techniques were −0.71 and
1.16, respectively (Fig. 5).
Discussion
Our results demonstrate that, in patients with documented
CAD, CFR estimated by SPECT sestamibi imaging using
first transit counts from PA is more accurate and correlates
better with the results of intracoronary Doppler than CFR
obtained using first transit counts from LV chamber. This
study has also shown a reduction in both stress and rest
estimated MBF when first transit counts are obtained from
LV chamber.
The feasibility of CFR measurement has been widely
investigated and its value well recognized. Gould and
Lipscomb [32] originally outlined the importance of
measuring CFR in clinical practice and were the first to
define the relationship between CFR and the severity of
coronary stenosis. Although there are some limitations,
Fig. 1 Stress and rest values of 99mTc-sestamibi-estimated myocardial
blood flow (MBF) obtained using first transit counts from pulmonary
artery and left ventricle
Fig. 2 Relationship between 99mTc-sestamibi-estimated CFR obtained
using first transit counts from the pulmonary artery (PA) and
intracoronary Doppler CFR
Fig. 3 Relationship between 99mTc-sestamibi-estimated CFR obtained
using first transit counts from the left ventricle (LV) and intracoronary
Doppler CFR
Fig. 4 Agreement between 99mTc-sestamibi-estimated CFR obtained
using first transit counts from the pulmonary artery (PA) and intra-
coronary Doppler CFR by Bland-Altman analysis. The differences
between the two techniques are plotted against the means of the two
techniques. The horizontal solid line indicates the mean difference
between the two techniques, and the dashed lines indicate the limits of
agreement (mean difference ± 1.96 times the SD of the difference)
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CFR measures can be achieved with both invasive and non-
invasive procedures [22, 33–40]. Intravascular Doppler
ultrasound transducer or pressure transducer attached to
the end of an angioplasty guide wire system, once the
system is placed into the coronary artery of interest, allows
assessing CFR invasively [11, 40, 41]. Essentially, this
technique evaluates coronary flow velocity reserve, which
is the ratio of intracoronary mean velocity under baseline
conditions to mean velocity after pharmacological induc-
tion of maximal hyperaemia. Because blood velocity is
proportional to flow for a constant vessel area, coronary
flow velocity reserve may be calculated from the hyper-
aemic flow divided by resting blood velocity in a vessel. In
our study an intracoronary Doppler wire was used to assess
CFR. No angiography was performed at the time of the
maximal effect of the dipyridamole infusion avoiding
changes in the lumen diameter of the coronary artery at
the site of Doppler measurements, which would have
affected volumetric flow assessment. Nevertheless, it has
been demonstrated that no change or minimal changes
occur in coronary diameter after intravenous adenosine or
dipyridamole administration and that slight vasodilatation
may occur in both normal and stenotic segments; as a
result, the percent diameter stenosis is not essentially
altered [42–44]. PET and SPECT represent non-invasive
methods to evaluate CFR. In particular, PET imaging with
15O water [13–15, 39] and 13N ammonia [45, 46] represents
the non-invasive gold standard for obtaining quantitative
regional blood flow and CFR, whereas 82Rb has been more
recently proposed as a possible agent for these purposes
[47, 48]. However, both intracoronary Doppler and cardiac
PET, because of their economic constraints and complicated
measures, may not be applied routinely in clinical assess-
ment. Recently, estimates of CFR with single photon tracers
achieved good agreement with the results obtained by
invasive methods [16, 19], even if Taki et al. [18]
demonstrated that the increase in myocardial retention of
99mTc-labelled agents underestimates CFR at high flow
rates. For patients with CAD we reported that sestamibi
imaging is an accurate and simple way to non-invasively
estimate CFR with good interobserver and intraobserver
reproducibility [16]. This procedure is based on the
microsphere method, which makes use of the fact that
sestamibi is taken up by the myocardium according to
blood flow. Factors related to low resolution, such as
scatter, attenuation and partial volume effects, hamper the
absolute quantitation of both arterial and tissue counts, but
they may be cancelled out by computing the ratio of tissue
and arterial counts. In addition, first-pass studies have
intrinsic difficulties such as the need for bolus integrity to
obtain best-fit gamma function or the individual character-
istics of great vessel anatomy in the adult population [49].
Another important factor affecting the accuracy of estimates
is the noise characteristics inherent to dynamic studies. It
can be a result of the movement of the patient within the
scanner and respiratory movement, as well as cardiac
motion.
From a methodological point of view, the procedure
chosen to obtain the arterial input function seems to
represent one of the most critical factors affecting the
accuracy of measurements. In fact, the use of a ROI
assigned either to the PA or to the ascending aorta has been
alternatively sustained in the estimation of MBF [17, 19,
20]. Provided that appropriate ROI are selected, first-pass
studies can yield reasonably accurate and reproducible
determinations of cardiac output. The use of a ROI
designed on the ascending aorta to measure first transit
counts was supported by Ito et al. [9] since this technique
may have the potential for greater reproducibility and be
less dependent on the bolus administration than is mea-
surement of the first transit counts in the PA. Conversely,
the method might have the potential to cause a relatively
large error in patients who have low cardiac output with a
very slow time-activity curve of the aorta. In the present
study all patients had an adequate time-activity curve
without insufficient bolus and none of them had impaired
LV function. This latter imaging approach was likely
gathered from PET studies [50–53], which used a blood
time-activity curve derived from a ROI drawn over
dynamic PET images of the left ventricle. Results from
these studies indicate that the time-activity curve obtained
from the LV ROI matched well with the arterial plasma
curve. It should be taking into account that ascending aorta
and left ventricle represent a unique comprehensive
Fig. 5 Agreement between 99mTc-sestamibi-estimated CFR obtained
using first transit counts from the left ventricle (LV) and intracoronary
Doppler CFR by Bland-Altman analysis. The differences between the
two techniques are plotted against the means of the two techniques.
The horizontal solid line indicates the mean difference between the
two techniques, and the dashed lines indicate the limits of agreement
(mean difference ± 1.96 times the SD of the difference)
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dynamic system as ventricular/vascular coupling can be
assessed from measurements of pressure and flow in the
ascending aorta (for left ventricle/systemic circulation) [54].
The integrated model of the left ventricle and aorta has been
postulated theoretically [55], studied in animals [56] and
investigated in humans by means of magnetic resonance
[57]. Another method promotes the use of a right PA ROI
to compute the arterial input function for the myocardial
perfusion measurements [16, 17]. Although it assumes that
the relative proportion of the tracer entering the right PA
does not differ between the pharmacological stress and rest
studies, differences could be detected in patients with
advanced obstructive pulmonary disease or with other
diseases affecting the lungs. As a result, both the above-
mentioned procedures used to compute arterial input
function appear to retain some concerns.
In our study we compared the values of CFR estimated
by sestamibi obtained using first transit counts from both
PA and LV chamber with those derived from intracoronary
Doppler. Although no significant differences were found in
CFR measures between the three methods, a significant
relationship between CFR estimated by sestamibi using first
transit counts from PA and CFR obtained by intracoronary
Doppler was observed. On the contrary, no relationship
between CFR estimated by sestamibi using first transit
counts from LV chamber and CFR obtained by intra-
coronary Doppler was found. Thus, the accuracy of the
arterial input function was improved by assigning a ROI at
the right PA. These results endorse the concept that
spillover from bordering cardiac structures may affect the
accuracy of measurement by sestamibi imaging when the
blood pool time-activity curve is derived from a ROI drawn
in the ascending aorta or in the LV chamber. Spillover from
tissue to the LV blood pool at late times is a more
complicated factor when the LV curve is to be used as an
input function in PET studies [49]. It depends on the
usually high extraction rate of positron-emitting tracers,
which does not represent a critical factor when SPECT
tracers are used to obtain dynamic images. However, using
sestamibi imaging, spillover to the left ventricle from the
right ventricle, and atria or to the ascending aorta from the
surrounding cardiac structures, should be usually encom-
passed. In addition, because most acquiring incidences
enclose the most part of cardiac chambers some of the noise
problems associated with the cardiac motion might not be
completely ruled out. To substantiate this hypothesis, we
considered SPECT-estimated stress and rest MBF obtained
using first transit counts from PA, which were higher as
compared to that from the left ventricle. A reduction in both
stress and rest MBF accounts for the occurrence of spillover
from bordering cardiac structures when left ventricle or
ascending aorta is used. Accordingly, CFR estimated by
sestamibi imaging obtained using first transit counts from
PA correlated well with the results of intracoronary
Doppler. Finally, it should be considered that the type of
stress might influence CFR measurements [58, 59]. In our
study protocol CFR was evaluated by use of dipyridamole
for stress testing during both radionuclide imaging and
intracoronary Doppler with similar haemodynamic changes
[16]. Dipyridamole can be infused at low, intermediate and
high dose [30]. Previous studies showed that the effect of
intermediate- and high-dose testing does not carry a greater
risk than low-dose testing [30, 60]. For the purpose of the
current study we employed an intermediate (0.74 mg/kg)
dipyridamole dosage.
Conclusion
SPECT-estimated CFR obtained using arterial input function
from right PA counts is more accurate and correlates better
with the results of intracoronary Doppler than estimated CFR
obtained using arterial input function from LV chamber.
Thus, the accuracy of arterial input function may be
improved by assigning a ROI at PA, avoiding spillover from
bordering cardiac structures that can be observed using the
LV chamber.
References
1. Nicolai E, Cuocolo A, Pace L, Nappi A, Sullo P, Cardei S, et al.
Adenosine coronary vasodilatation quantitative technetium 99m
methoxy isobutyl isonitrile myocardial tomography in the identifica-
tion and localization of coronary artery disease. J Nucl Cardiol
1996;3:9–17. doi:10.1016/S1071-3581(96)90019-7.
2. Miller DD, Younis LT, Chaitman BR, Stratmann H. Diagnostic
accuracy of dipyridamole technetium 99m-labelled sestamibi
myocardial tomography for detection of coronary artery disease. J
Nucl Cardiol 1997;4:18–24. doi:10.1016/S1071-3581(97)90045-3.
3. Heller GV, Herman SD, Travin MI, Baron JI, Santos-Ocampo C,
McClellan JR. Independent prognostic value of intravenous
dipyridamole with technetium-99m sestamibi tomographic imaging
in predicting cardiac events and cardiac-related hospital admissions. J
Am Coll Cardiol 1995;26:1202–8. doi:10.1016/0735-1097(95)
00329-0.
4. Stratmann HG, Tamesis BR, Younis LT, Wittry MD, Amato M,
Miller DD. Prognostic value of predischarge dipyridamole
technetium 99m sestamibi myocardial tomography in medically
treated patients with unstable angina. Am Heart J 1995;130:734–40.
doi:10.1016/0002-8703(95)90071-3.
5. Garcia EV. Quantitative myocardial perfusion single-photon
emission computed tomographic imaging: quo vadis? J Nucl
Cardiol 1994;1:83–93. doi:10.1007/BF02940015.
6. Germano G. Technical aspects of myocardial SPECT imaging. J
Nucl Med 2001;42:1499–507.
7. Klocke FJ. Measurements of coronary flow reserve: defining
pathophysiology versus making decisions about patient care.
Circulation 1987;76:1183–9.
8. Hoffman JI. A critical view of coronary reserve. Circulation
1987;75:I6–11.
9. Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for
assessing critical coronary stenosis. Instantaneous flow response
Eur J Nucl Med Mol Imaging (2009) 36:2034–2041 2039
and regional distribution during coronary hyperemia as measures
of coronary flow reserve. Am J Cardiol 1974;33:87–94.
doi:10.1016/0002-9149(74)90743-7.
10. Baller D, Notohamiprodjo G, Gleichmann U, Holzinger J, Weise R,
Lehmann J. Improvement in coronary flow reserve determined by
positron emission tomography after 6 months of cholesterol-lowering
therapy in patients with early stages of coronary atherosclerosis.
Circulation 1999;99:2871–5.
11. Doucette JW, Corl PD, Payne HM, Flynn AE, Goto M, Nassi M,
et al. Validation of a Doppler guide wire for intravascular
measurement of coronary artery flow velocity. Circulation
1992;85:1899–911.
12. Aude YW, Garza L. How to prevent unnecessary coronary
interventions: identifying lesions responsible for ischemia in the
cath lab. Curr Opin Cardiol 2003;18:394–9. doi:10.1097/
00001573-200309000-00012.
13. Bergmann SR, Fox KA, Rand AL, McElvany KD, Welch MJ,
Markham J, et al. Quantification of regional myocardial blood
flow in vivo with H215O. Circulation 1984;70:724–33.
14. Araujo LI, Lammertsma AA, Rhodes CG, McFalls EO, Iida H,
Rechavia E, et al. Noninvasive quantification of regional myocardial
blood flow in coronary artery disease with oxygen-15-labeled carbon
dioxide inhalation and positron emission tomography. Circulation
1991;83:875–85.
15. Iida H, Kanno I, Takahashi A, Miura S, Murakami M, Takahashi K,
et al. Measurement of absolute myocardial blood flow with
H215O and dynamic positron-emission tomography. Strategy
for quantification in relation to the partial-volume effect.
Circulation 1988;78:104–15.
16. Storto G, Cirillo P, Vicario ML, Pellegrino T, Sorrentino AR,
Petretta M, et al. Estimation of coronary flow reserve by Tc-99m
sestamibi imaging in patients with coronary artery disease:
comparison with the results of intracoronary Doppler technique.
J Nucl Cardiol 2004;11:682–8. doi:10.1016/j.nuclcard.2004.08.007.
17. Sugihara H, Yonekura Y, Kataoka K, Fukai D, Kitamura N,
Taniguchi Y. Estimation of coronary flow reserve with the use of
dynamic planar and SPECT images of Tc-99m tetrofosmin. J Nucl
Cardiol 2001;8:575–9. doi:10.1067/mnc.2001.115934.
18. Taki J, Fujino S, Nakajima K, Matsunari I, Okazaki H, Saga T, et al.
(99m)Tc-sestamibi retention characteristics during pharmacologic
hyperemia in human myocardium: comparison with coronary flow
reserve measured by Doppler flowire. J Nucl Med 2001;42:1457–63.
19. Ito Y, Katoh C, Noriyasu K, Kuge Y, Furuyama H, Morita K, et al.
Estimation of myocardial blood flow and myocardial flow
reserve by 99mTc-sestamibi imaging: comparison with the
results of [15O]H2O PET. Eur J Nucl Med Mol Imaging
2003;30:281–7.
20. Brunken RC. Challenges for measurement of myocardial perfusion
and perfusion reserve by SPECT imaging. J Nucl Cardiol
2007;14:145–9. doi:10.1016/j.nuclcard.2007.01.034.
21. Ragosta M. The clinical assessment of coronary flow reserve
in patients with coronary artery disease. J Nucl Cardiol
2004;11:651–5. doi:10.1016/j.nuclcard.2004.09.010.
22. Gullberg GT, Di Bella EV, Sinusas AJ. Estimation of coronary
flow reserve: can SPECT compete with other modalities? J Nucl
Cardiol 2001;8:620–5. doi:10.1067/mnc.2001.118121.
23. Vicario ML, Cirillo L, Storto G, Pellegrino T, Ragone N,
Fontanella L, et al. Influence of risk factors on coronary flow
reserve in patients with 1-vessel coronary artery disease. J Nucl
Med 2005;46:1438–43.
24. Pellegrino T, Storto G, Filardi PP, Sorrentino AR, Silvestro A,
Petretta M, et al. Relationship between brachial artery flow-
mediated dilation and coronary flow reserve in patients with
peripheral artery disease. J Nucl Med 2005;46:1997–2002.
25. Storto G, Pellegrino T, Sorrentino AR, Luongo L, Petretta M,
Cuocolo A. Estimation of coronary flow reserve by sestamibi
imaging in type 2 diabetic patients with normal coronary arteries. J
Nucl Cardiol 2007;14:194–9. doi:10.1016/j.nuclcard.2006.12.327.
26. Perrone-Filardi P, Cuocolo A, Brevetti G, Silvestro A, Storto G,
Dellegrottaglie S, et al. Relation of brachial artery flow-mediated
vasodilation to significant coronary artery disease in patients with
peripheral arterial disease. Am J Cardiol 2005;96:1337–41.
doi:10.1016/j.amjcard.2005.06.084.
27. Storto G, Sorrentino AR, Pellegrino T, Liuzzi R, Petretta M,
Cuocolo A. Assessment of coronary flow reserve by sestamibi
imaging in patients with typical chest pain and normal coronary
arteries. Eur J Nucl Med Mol Imaging 2007;34:1156–61.
doi:10.1007/s00259-006-0333-x.
28. Palmieri V, Storto G, Arezzi E, Pellegrino T, Mancini M, Di
Minno G, et al. Relations of left ventricular mass and systolic
function to endothelial function and coronary flow reserve in
healthy, new discovered hypertensive subjects. J Hum Hypertens
2005;19:941–50. doi:10.1038/sj.jhh.1001921.
29. Petretta M, Soricelli A, Storto G, Cuocolo A. Assessment of
coronary flow reserve using single photon emission computed
tomography with technetium 99m-labeled tracers. J Nucl Cardiol
2008;15:456–65. doi:10.1016/j.nuclcard.2008.03.008.
30. Lette J, Tatum JL, Fraser S, Miller DD, Waters DD, Heller G, et al.
Safety of dipyridamole testing in 73,806 patients: the Multicenter
Dipyridamole Safety Study. J Nucl Cardiol 1995;2:3–17.
doi:10.1016/S1071-3581(05)80003-0.
31. Bland JM, Altman DG. Statistical methods for assessing agreement
between twomethods of clinical measurement. Lancet 1986;1:307–10.
32. Gould KL, Lipscomb K. Effects of coronary stenoses on coronary
flow reserve and resistance. Am J Cardiol 1974;34:48–55.
doi:10.1016/0002-9149(74)90092-7.
33. Marcus ML, Wilson RF, White CW. Methods of measurement of
myocardial blood flow in patients: a critical review. Circulation
1987;76:245–53.
34. Hoffman JI. Problems of coronary flow reserve. Ann Biomed Eng
2000;28:884–96. doi:10.1114/1.1308503.
35. De Bruyne B, Baudhuin T, Melin JA, Pijls NH, Sys SU, Bol A, et al.
Coronary flow reserve calculated from pressure measurements in
humans. Validation with positron emission tomography. Circulation
1994;89:1013–22.
36. Saraste M, Koskenvuo J, Knuuti J, Toikka J, Laine H, Niemi P,
et al. Coronary flow reserve measurement with transthoracic
Doppler echocardiography is reproducible and comparable with
positron emission tomography. Clin Physiol 2001;21:114–22.
doi:10.1046/j.1365-2281.2001.00296.x.
37. Germain P, Roul G, Baruthio J, Jahn C, Coulbois PM, Dumitresco B,
et al. Myocardial flow reserve parametric map, assessed by first-pass
MRI compartmental analysis at the chronic stage of infarction. J
Magn Reson Imaging 2001;13:352–60. doi:10.1002/jmri.1050.
38. Koskenvuo JW, Sakuma H, Niemi P, Toikka JO, Knuuti J, Laine H,
et al. Global myocardial blood flow reserve measurements by MRI
and PET are comparable. J Magn Reson Imaging 2001;13:361–6.
doi:10.1002/jmri.1051.
39. Bergmann SR, Herrero P, Markham J, Weinheimer CJ, Walsh MN.
Noninvasive quantitation of myocardial blood flow in human
subjects with oxygen-15-labeled water and positron emission
tomography. J Am Coll Cardiol 1989;14:639–52.
40. Joye JD, Schulman DS. Clinical application of coronary flow
reserve using an intracoronary Doppler guide wire. Cardiol Clin
1997;15:101–29. doi:10.1016/S0733-8651(05)70321-0.
41. Labovitz AJ, Anthonis DM, Cravens TL, Kern MJ. Validation of
volumetric flow measurements by means of a Doppler-tipped
coronary angioplasty guide wire. Am Heart J 1993;126:1456–61.
doi:10.1016/0002-8703(93)90545-K.
42. Kern MJ, Deligonul U, Tatineni S, Serota H, Aguirre F, Hilton TC.
Intravenous adenosine: continuous infusion and low dose bolus
administration for determination of coronary vasodilator reserve in
2040 Eur J Nucl Med Mol Imaging (2009) 36:2034–2041
patients with and without coronary artery disease. J Am Coll Cardiol
1991;18:718–29.
43. Rossen JD, Quillen JE, Lopez AG, Stenberg RG, Talman CL,
Winniford MD. Comparison of coronary vasodilatation with
intravenous dipyridamole and adenosine. J Am Coll Cardiol
1991;18:485–91.
44. Ogilby JD, Iskandrian AS, Untereker WJ, Heo J, Nguyen TN,
Mercuro J. Effect of intravenous adenosine infusion on myocardial
perfusion and function. Hemodynamic/angiographic and
scintigraphic study. Circulation 1992;86:887–95.
45. Masuda D, Nohara R, Tamaki N, Hosokawa R, Inada H, Hikai T,
et al. Evaluation of coronary blood flow reserve by 13 N-NH3
positron emission computed tomography (PET) with dipyridamole
in the treatment of hypertension with the ACE inhibitor
(Cilazapril). Ann Nucl Med 2000;14:353–60. doi:10.1007/
BF02988695.
46. Yokoyama I, Ohtake T, Momomura S, Nishikawa J, Sasaki Y,
Omata M. Reduced coronary flow reserve in hypercholesterolemic
patients without overt coronary stenosis. Circulation 1996;94:3232–8.
47. Lortie M, Beanlands RS, Yoshinaga K, Klein R, Dasilva JN,
DeKemp RA. Quantification of myocardial blood flow with 82Rb
dynamic PET imaging. Eur J Nucl Med Mol Imaging
2007;34:1765–74. doi:10.1007/s00259-007-0478-2.
48. Lautamäki R, George RT, Kitagawa K, Higuchi T, Merrill J, Voicu C,
et al. Rubidium-82 PET-CT for quantitative assessment of myocar-
dial blood flow: validation in a canine model of coronary artery
stenosis. Eur J Nucl Med Mol Imaging 2009;36:576–86.
doi:10.1007/s00259-008-0972-1.
49. Castell-Conesa J, Candell-Riera J. Estimation of coronary flow
reserve by SPECT: myth or reality? Eur J Nucl Med Mol Imaging
2007;34:1152–5. doi:10.1007/s00259-007-0415-4.
50. Gambhir SS, SchwaigerM, Huang SC, Krivokapich J, Schelbert HR,
Nienaber CA, et al. Simple noninvasive quantification method for
measuring myocardial glucose utilization in humans employing
positron emission tomography and fluorine-18 deoxyglucose. J Nucl
Med 1989;30:359–66.
51. Santana CA, Folks RD, Garcia EV, Verdes L, Sanyal R, Hainer J,
et al. Quantitative (82)Rb PET/CT: development and validation of
myocardial perfusion database. J Nucl Med 2007;48:1122–8.
doi:10.2967/jnumed.107.039750.
52. Katoh C, Morita K, Shiga T, Kubo N, Nakada K, Tamaki N.
Improvement of algorithm for quantification of regional myocardial
blood flow using 15O-water with PET. J NuclMed 2004;45:1908–16.
53. Choi Y, Hawkins RA, Huang SC, Gambhir SS, Brunken RC,
Phelps ME, et al. Parametric images of myocardial metabolic rate
of glucose generated from dynamic cardiac PET and 2-[18F]
fluoro-2-deoxy-d-glucose studies. J Nucl Med 1991;32:733–8.
54. O’Rourke MF, Yaginuma T, Avolio AP. Physiological and
pathophysiological implications of ventricular/vascular coupling.
Ann Biomed Eng 1984;12:119–34. doi:10.1007/BF02584226.
55. Nakamura M, Wada S, Yamaguchi T. Computational analysis of
blood flow in an integrated model of the left ventricle and the
aorta. J Biomech Eng 2006;128:837–43. doi:10.1115/1.2400864.
56. Perlini S, Soldà PL, Piepoli M, Calciati A, ParoM,Marchetti G, et al.
Time course of pressure and flow in ascending aorta during ejection.
Int J Cardiol 1991;30:169–79. doi:10.1016/0167-5273(91)90092-4.
57. Long Q, Merrifield R, Xu XY, Kilner P, Firmin DN, G-Z Y.
Subject-specific computational simulation of left ventricular flow
based on magnetic resonance imaging. Proc Inst Mech Eng [H]
2008;222:475–85. doi:10.1243/09544119JEIM310.
58. McGinn AL, White CW, Wilson RF. Interstudy variability of
coronary flow reserve. Influence of heart rate, arterial pressure,
and ventricular preload. Circulation 1990;81:1319–30.
59. Scherhag AW, Pfleger S, de Mey C, Schreckenberger AB, Staedt U,
Heene DL. Continuous measurement of hemodynamic alterations
during pharmacologic cardiovascular stress using automated imped-
ance cardiography. J Clin Pharmacol 1997;37(Suppl):21S–8S.
doi:10.1177/009127009703700118.
60. Varga A, Garcia MA, Picano E, International Stress Echo
Complication Registry. Safety of stress echocardiography (from
the International Stress Echo Complication Registry). Am J
Cardiol 2006;98:541–3. doi:10.1016/j.amjcard.2006.02.064.
Eur J Nucl Med Mol Imaging (2009) 36:2034–2041 2041
